How is Intervigilance Different?
Trusted Expertise - Global Competence
At InterVigilance we believe that all biopharmaceutical companies need robust drug safety strategies and effective operations to be successful. We understand the pressure organizations are under when it comes to protecting patients, and at the same time their products and commercial goals, whilst continuously adapting to regulatory change, legal challenges, cost-pressures and new market requirements.
In such a complex and fast-changing environment across an intricate array of internal and external stakeholders and vendors, even small strategic or organizational weaknesses can have far reaching consequences, such as prolonged clinical trials, delayed product launches, restrictions in indications and labelling, or the need for multi-million dollar investments for additional safety studies or clinical trials.
Most challenges safety organizations face are either entirely avoidable, or can be mitigated before major damage is done through integrated strategies and operational excellence.
InterVigilance works with clients to reduce operational safety risks and create enterprise value by helping to develop and implement state-of-the-art safety management strategies.
But our support does not stop there! We understand that there is not one solution that fits all companies. But we also know that in many cases even minor changes to safety strategy and management applying tested principles will have immediate positive impact if executed effectively.
Our range of targeted and hands-on services will not only transform the way our clients approach safety management, but also focus on successful implementation and operational execution of those strategies to achieve business goals.